Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wade L Thorstad

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2022
<sup>18</sup>F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002Rathan M Subramaniam, Lyudmila DeMora, Min Yao, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck CancerLoren K Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, et al.
Cancer|March 27, 2019
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trialsCarole Fakhry, Qiang Zhang, Maura L Gillison, et al.
Cancer|June 2, 2020
Management of primary skin cancer during a pandemic: Multidisciplinary recommendationsBrian C Baumann, Kelly M MacArthur, Jerry D Brewer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2017
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal CancerCarole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
The Journal of Clinical Investigation|March 2, 2021
Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinomaCan F Koyuncu, Cheng Lu, Kaustav Bera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics|September 22, 2018
In Regard to Bossi et alCarole Fakhry, Phuc Felix Nguyen-Tân, Louise Lambert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)Sue S Yom, Pedro Torres-Saavedra, Jimmy J Caudell, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2022
<sup>18</sup>F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002Rathan M Subramaniam, Lyudmila DeMora, Min Yao, et al.
Cancer|July 16, 2016
Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Vasu Divi, Jonathan Harris, Paul M Harari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck CancerLoren K Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, et al.
Cancer|March 27, 2019
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trialsCarole Fakhry, Qiang Zhang, Maura L Gillison, et al.
Cancer|June 2, 2020
Management of primary skin cancer during a pandemic: Multidisciplinary recommendationsBrian C Baumann, Kelly M MacArthur, Jerry D Brewer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2017
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal CancerCarole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
The Journal of Clinical Investigation|March 2, 2021
Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinomaCan F Koyuncu, Cheng Lu, Kaustav Bera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics|September 22, 2018
In Regard to Bossi et alCarole Fakhry, Phuc Felix Nguyen-Tân, Louise Lambert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)Sue S Yom, Pedro Torres-Saavedra, Jimmy J Caudell, et al.
Pageof 10